Guillermo
Debén Ariznavarreta
Hospital Universitario de Jaén
Jaén, EspañaPublications in collaboration with researchers from Hospital Universitario de Jaén (1)
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433